Dubna is launching the production of solid dosage forms, which will allow the production of more than 70 million capsules and about 150 million tablets per year.

The company already produces antibiotics and antibacterial drugs for the treatment of complex infections. Now, thanks to the expansion of capacity, production will grow by 30% in 2025. The company’s products are supplied not only to Russia, but also to the CIS countries and Mongolia.

@blackponed